Literature DB >> 2067654

Cholesterol-lowering agent myopathy (CLAM).

S F London1, K F Gross, S P Ringel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2067654     DOI： 10.1212/wnl.41.7.1159

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  3 in total

1.  Single-fiber electromyography in hyperCKemia: the value of fiber density.

Authors:  D A Restivo; V Pavone; A Nicotra
Journal:  Neurol Sci       Date:  2011-11-09       Impact factor: 3.307

Review 2.  Gemfibrozil. A reappraisal of its pharmacological properties and place in the management of dyslipidaemia.

Authors:  C M Spencer; L B Barradell
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

3.  Effectiveness of Coelatura aegyptiaca Extract Combination with Atorvastatin on Experimentally Induced Hyperlipidemia in Rats.

Authors:  Ayman Saber Mohamed; Walaa Mohammed Ibrahim; Nashwah Ismail Zaki; Sara Bayoumi Ali; Amel M Soliman
Journal:  Evid Based Complement Alternat Med       Date:  2019-01-01       Impact factor: 2.629
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.